• Cisplatin (SKU A8321): Optimizing Apoptosis and Chemoresi...

  2026-04-08

  Explore how Cisplatin (SKU A8321) addresses common laboratory challenges in cancer research, from apoptosis assay reliability to chemoresistance modeling. This scenario-driven guide presents evidence-based strategies for experimental design, data interpretation, and vendor selection, positioning Cisplatin as a reproducible, high-quality solution for biomedical researchers.

• Diclofenac (SKU B3505): Reliable COX Inhibition for Infla...

  2026-04-08

  This article addresses real-world challenges in inflammation and pharmacokinetic assays, focusing on the use of high-purity Diclofenac (SKU B3505) as a non-selective COX inhibitor. It delivers scenario-driven, evidence-based guidance to help biomedical researchers and lab technicians optimize reproducibility and data quality, highlighting APExBIO’s validated product as a benchmark for reliability across advanced organoid and cell-based workflows.

• Ibuprofen in Experimental Oncology: Mechanisms, Assay Opt...

  2026-04-07

  Explore the advanced applications of Ibuprofen as a cyclooxygenase inhibitor in cancer biology, with a unique focus on apoptosis induction, cell cycle arrest, and lipid metabolism modulation. This in-depth article uncovers mechanistic insights and practical assay guidance, expanding beyond standard anti-inflammatory research.

• Angiotensin III (human, mouse): Core RAAS Peptide for Car...

  2026-04-07

  Angiotensin III (human, mouse) is a validated renin-angiotensin-aldosterone system (RAAS) peptide with robust pressor and aldosterone-stimulating activity. As an AT1 and AT2 receptor ligand, it enables precise modeling of cardiovascular and neuroendocrine pathways, with high purity and solubility supporting diverse experimental workflows.

• Ibuprofen: A Cyclooxygenase Inhibitor for Cancer and Athe...

  2026-04-06

  Ibuprofen’s dual COX-1/COX-2 inhibition and apoptosis-inducing capabilities make it indispensable for advanced studies in colon cancer and lipid metabolism. This guide details optimized workflows, troubleshooting strategies, and experimental innovations powered by APExBIO’s high-purity Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid). Discover how to maximize reproducibility and mechanistic insights across inflammation, cancer biology, and atherosclerosis models.

• Cisplatin in Cancer Research: Linking DNA Damage to RNA m...

  2026-04-06

  Explore the multifaceted role of cisplatin, a gold-standard chemotherapeutic compound, as both a DNA crosslinking agent and a tool to probe RNA m6A homeostasis and genome stability in cancer research. Discover advanced mechanistic insights, emerging applications, and translational strategies beyond conventional apoptosis assays.

• Angiotensin III (human, mouse): Core RAAS Peptide for Car...

  2026-04-05

  Angiotensin III (human, mouse) is a validated renin-angiotensin-aldosterone system (RAAS) peptide that robustly induces aldosterone secretion and mediates pressor activity. As a precise AT1 and AT2 receptor ligand, it supports reproducible cardiovascular and neuroendocrine research protocols.

• Cisplatin as a Mechanistic Probe: DNA Damage, Apoptosis, ...

  2026-04-04

  Explore how Cisplatin, a gold-standard DNA crosslinking agent, enables precise mechanistic studies in cancer research. This article uniquely examines its roles in apoptosis, oxidative stress, and chemoresistance, providing a deeper analysis than typical application guides.

• Diclofenac: Non-Selective COX Inhibitor for Inflammation ...

  2026-04-03

  Diclofenac is a highly pure, non-selective cyclooxygenase (COX) inhibitor widely used for inflammation and pain signaling research. Its robust solubility in DMSO and ethanol, combined with reliable inhibition of prostaglandin synthesis, make it a gold standard compound for COX enzyme assays and advanced organoid pharmacokinetic models. This dossier clarifies Diclofenac’s properties, best practices, and critical boundaries for research use.

• (S)-(+)-Ibuprofen: Mechanistic Insights and Emerging Fron...

  2026-04-03

  (S)-(+)-Ibuprofen, the pharmacologically active ibuprofen enantiomer, is a cornerstone COX inhibitor for advanced inflammation and pain mechanism studies. This article delivers a distinctive, in-depth analysis of its mechanistic action, synthetic progress, and next-generation applications—bridging molecular insights with translational research opportunities.

• Cisplatin in Cancer Research: Mechanisms, Chemoresistance...

  2026-04-02

  Explore the multifaceted role of Cisplatin as a DNA crosslinking agent for cancer research, with a special focus on apoptosis, chemoresistance, and patient-derived xenograft models. Uncover advanced scientific insights and practical guidance on leveraging Cisplatin’s mechanisms for translational oncology.

• (S)-(+)-Ibuprofen: Selective COX Inhibitor for Inflammati...

  2026-04-02

  (S)-(+)-Ibuprofen is a pharmacologically active ibuprofen enantiomer and a benchmark COX inhibitor widely used in inflammation pathway and pain mechanism studies. Its selective inhibition of COX-1 and COX-2, along with high solubility in DMSO and ethanol, make it ideal for in vitro and in vivo research. Compared to its R-enantiomer, (S)-(+)-Ibuprofen exhibits stronger activity and fewer side effects.

• Angiotensin III (human, mouse): Advanced Mechanistic Insi...

  2026-04-01

  Discover the multifaceted role of Angiotensin III, a key renin-angiotensin-aldosterone system peptide, as both an aldosterone secretion inducer and a pressor activity mediator. This article provides in-depth analysis of its unique receptor interactions, translational applications, and emerging implications for cardiovascular, neuroendocrine, and viral pathogenesis research.

• (S)-(+)-Ibuprofen: Chemical Structure, COX Inhibition, an...

  2026-04-01

  (S)-(+)-Ibuprofen is the pharmacologically active ibuprofen enantiomer, renowned for selective COX inhibition and translational research value. This article uniquely explores its chemical makeup, cutting-edge assay applications, and future directions for inflammation and pain management science.

• Cisplatin in Cancer Research: From Molecular Mechanisms t...

  2026-03-31

  Explore the multifaceted role of Cisplatin as a DNA crosslinking agent for cancer research, with a special focus on apoptosis, chemoresistance, and the interplay with immune checkpoint regulation. Discover how cutting-edge insights into ER stress and PD-L1 stabilization open new avenues for therapeutic innovation.

16295 records 1/1087 page Next 12345 下5页 Last page